Prostate-Specific Antigen After Neoadjuvant Androgen Suppression in Prostate Cancer Patients Receiving Short-Term Androgen Suppression and External Beam Radiation Therapy: Pooled Analysis of Four NRG Oncology Radiation Therapy Oncology Group Randomized Clinical Trials-Reference-Cited by-同舟云学术

Prostate-Specific Antigen After Neoadjuvant Androgen Suppression in Prostate Cancer Patients Receiving Short-Term Androgen Suppression and External Beam Radiation Therapy: Pooled Analysis of Four NRG Oncology Radiation Therapy Oncology Group Randomized Clinical Trials

Published:2019-08 Issue:5 Volume:104 Page:1057-1065
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Hallemeier Christopher L.,Zhang Peixin,Pisansky Thomas M.,Hanks Gerald E.,McGowan David G.,Roach Mack,Zeitzer Kenneth L.,Firat Selim Y.,Husain Siraj M.,D'Souza David P.,Souhami Luis,Parliament Matthew B.,Rosenthal Seth A.,Lukka Himanshu R.,Rotman Marvin,Horwitz Eric M.,Miles Edward F.,Paulus Rebecca,Sandler Howard M.

Funder

NRG Oncology Operations

NRG Oncology SDMC

Radiation Therapy Oncology Group-Ops-Stat

National Cancer Institute

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference34 articles.

1. Radiotherapy and short-term androgen deprivation for localized prostate cancer;Jones;N Engl J Med,2011

2. Duration of androgen suppression before radiotherapy for localized prostate cancer: Radiation Therapy Oncology Group randomized clinical trial 9910;Pisansky;J Clin Oncol,2015